US2016279068A1PendingUtilityA1
Microparticles, methods for their preparation and use
Est. expiryNov 8, 2033(~7.3 yrs left)· nominal 20-yr term from priority
Inventors:Stefanie UtechRadivoje ProdanovicEsther AmstadRaluca OstafeDavid A. WeitzAngelo S. MaoDavid J. MooneyConnie Chang WilkingWang Huanan
A61K 9/1652A61K 35/00A61K 9/5036A61K 9/5089
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to microparticles comprising a crosslinked gel and methods for making and using same.
Claims
exact text as granted — not AI-modified1 . Microparticles comprising:
a crosslinked gel; wherein the microparticles have a coefficient of variation in the size distribution of the microparticles of from about 0.03 to about 0.05 and wherein the microparticles have at least one dimension measuring from about 5 μm to about 200 μm.
2 . The microparticles of claim 1 , wherein the crosslinked gel comprises one or more crosslinked linear polysaccharides.
3 . (canceled)
4 . (canceled)
5 . The microparticles of claim 2 , wherein the crosslinked linear polysaccharide comprises a crosslinking agent.
6 . The microparticles of claim 5 , wherein the crosslinking agent comprises divalent cations.
7 . (canceled)
8 . The microparticles of claim 1 , wherein the microparticles are substantially spherical or are rod-, crescent- or hook-shaped.
9 . (canceled)
10 . The microparticles of claim 8 , wherein the microparticles are core-shell microparticles.
11 . (canceled)
12 . The microparticles of claim 10 , wherein the core is a liquid core, a solid core or a gas core.
13 . (canceled)
14 . (canceled)
15 . The microparticles of claim 10 , wherein at least one of the core and the shell comprises one or more cells.
16 . The microparticles of claim 1 , wherein the microparticles comprise an active agent, magnetic nanoparticles, or pores.
17 . (canceled)
18 . (canceled)
19 . (canceled)
20 . (canceled)
21 . Microparticles comprising:
a Ca 2+ -crosslinked alginate gel; wherein the microparticles have a coefficient of variation in the size distribution of the microparticles of from about 0.03 to about 0.05 and wherein the microparticles have at least one dimension measuring from about 5 μm to about 200 μm.
22 . A method of forming the microparticles of claim 1 , the method comprising:
forming microdroplets comprising one or more crosslinkable linear polysaccharides and one or more crosslinking agents; contacting the microdroplets with a crosslinking promoter to promote crosslinking of the one or more crosslinkable linear polysaccharides.
23 . The method of claim 22 , wherein the crosslinking agent does not substantially crosslink the one or more crosslinkable linear polysaccharides in an initial state, but, upon contacting with the crosslinking promoter, crosslinks the one or more crosslinkable linear polysaccharides in a second state.
24 . The method of claim 23 , wherein the first state comprises a sequestered state of the one or more crosslinking agents and the second state comprises an unsequestered state of the one or more crosslinking agents.
25 . (canceled)
26 . The method of claim 22 , wherein said forming comprises microfluidically forming the microdroplets.
27 . The method of claim 22 , wherein crosslinking agent comprises divalent cations.
28 . (canceled)
29 . The method of claim 27 , wherein the divalent cations are sequestered.
30 . The method of claim 29 , wherein the sequestered divalent cations are chelated.
31 . The method of claim 30 , wherein the chelated divalent cations comprise Ca 2+ -EDTA.
32 . The method of claim 22 , wherein said crosslinking promoter comprises a change in the pH, a change in the temperature, a change in the ionic strength or combinations thereof.
33 . The method of claim 32 , wherein said crosslinking promoter comprises a change in the pH.
34 . The method of claim 33 , wherein the change in the pH is effected with an acid.
35 . (canceled)
36 . (canceled)
37 . (canceled)
38 . The method of claim 27 , wherein the divalent cations are sequestered and the crosslinking promoter causes sequestered divalent cations to be sufficiently freed from sequestration such that crosslinking of the one or more crosslinkable linear polysaccharides is promoted.
39 . A method of forming the microparticles of claim 21 , the method comprising:
forming microdroplets comprising alginate and Ca 2+ -EDTA; and contacting the microdroplets with a crosslinking promoter to promote crosslinking of the alginate.
40 . A method for delivering one or more microparticles of claim 1 to a location in a subject in need thereof or to an area in need thereof the method comprising (i) providing or obtaining one or more microparticle comprising an active agent; and (ii) delivering the microparticle to a location in a subject in need thereof or a location in an area in need thereof.
41 . A system comprising one or more microparticles of claim 1 and one or more cells encapsulated in the one or more microparticles.
42 . (canceled)Join the waitlist — get patent alerts
Track US2016279068A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.